For retail sale medicaments with insulin or hormones or antibiotics market in Croatia

Earlier Report Observations

Between 2018 and 2024, the Croatian market for retail-packed medicaments containing insulin, hormones, or antibiotics grew from $150.6 million to $222.4 million, peaking at $231.8 million in 2023. A significant expansion occurred in 2020 when the market size surged by 30% to $199.2 million, accompanied by a sharp rise in domestic production to $134.4 million. This growth phase continued into 2021 before a slight contraction in 2022, with the market recovering to its highest point the following year.

The market eased to $222.4 million in 2024 as production declined to $138.3 million and exports increased substantially. This period was marked by a major investment from Pfizer and Sobi to construct a new pharmaceutical production plant in Croatia, scheduled for completion by the end of 2024, signaling an expansion of local manufacturing capacity. Concurrently, EU-wide efforts to modernize pharmaceutical legislation, including the introduction of a Union list of Critical Medicines covering insulin, aimed at strengthening supply chain resilience for essential drugs.

Production for retail sale medicaments with insulin or hormones or antibiotics in Croatia

In value, 2017-2020, M $ US

Croatia's production of retail sale medicaments containing insulin, hormones, or antibiotics has increased for the third consecutive year. In 2020, output reached 134.4 million US dollars, marking a 40.6% rise from the previous year. From 2017 to 2020, production grew by 73.6%, which translates to an annualized growth rate of 20.2%.

Annual dynamics of production in Croatia in value, 2017-2020, M $ US

Exports for retail sale medicaments with insulin or hormones or antibiotics from Croatia

Exports in kind, t

Export volumes of retail sale medicaments with insulin, hormones, or antibiotics from Croatia have risen for the third year in a row. In 2020, exports totaled 104.7 tonnes, reflecting an 18.5% increase compared to 2019. Between 2017 and 2020, exports expanded by 34.7%, equivalent to an annualized growth rate of 10.4%.

Annual dynamics of product's exports from Croatia in kind, 2017-2020, t

From 2017 to 2020, the United Kingdom, Slovenia, and Bosnia and Herzegovina were the key export partners for Croatia's retail sale medicaments containing insulin, hormones, or antibiotics in volume terms. The United Kingdom accounted for 66.9% of exports, Slovenia for 8.2%, and Bosnia and Herzegovina for 4.5%, together representing 79.5% of total export flows.

Structure of product's exports in kind by countries, 2017-2020

World map of product's exports from Croatia in kind, 2017-2020

Exports in value, K $ US

After two years of decline, Croatia's exports of retail sale medicaments with insulin, hormones, or antibiotics rebounded in 2020. Exports reached 29 653 thousand US dollars, a 21.8% year-on-year increase. However, from 2017 to 2020, overall exports decreased by 7.7%, averaging an annual decline of 2.6%. The lowest value was recorded in 2019 at 24 341 thousand US dollars, following the largest drop of 14.5% in 2018.

Annual dynamics of product's exports from Croatia in value, 2017-2020, K $ US

Between 2017 and 2020, the United Kingdom and Germany dominated Croatia's exports of retail sale medicaments containing insulin, hormones, or antibiotics in value terms, jointly accounting for 83.9% of total exports. Other countries contributed to a more diversified but less significant portion of the export market.

Structure of product's exports in value by countries, 2017-2020

World map of product's exports from Croatia in value, 2017-2020

Imports for retail sale medicaments with insulin or hormones or antibiotics to Croatia

Imports in kind, t

Croatia's imports of retail sale medicaments with insulin, hormones, or antibiotics have increased for the third consecutive year. In 2020, imports amounted to 351.9 tonnes, up 9.9% from 2019. From 2017 to 2020, imports grew by 33.8%, corresponding to an annualized growth rate of 10.2%.

Annual dynamics of product's imports to Croatia in kind, 2017-2020, t

During the 2017–2020 period, Denmark, Hungary, and Germany were the leading sources for Croatia's imports of retail sale medicaments containing insulin, hormones, or antibiotics in volume terms. Denmark held a 32.6% share, Hungary 26.7%, and Germany 15.1%, together making up 74.5% of total import flows.

Structure of product's imports in kind by countries, 2017-2020

World map of product's imports to Croatia in kind, 2017-2020

Imports in value, K $ US

In 2020, Croatia's imports of retail sale medicaments with insulin, hormones, or antibiotics totaled 94 417 thousand US dollars, a 15.3% increase from the previous year. From 2017 to 2020, imports rose by 27.3%, averaging an annual growth rate of 8.4%. The largest increase occurred in 2018 at 15.4%, while the largest decline was in 2019 at 4.3%.

Annual dynamics of product's imports to Croatia in value, 2017-2020, K $ US

From 2017 to 2020, Hungary, Denmark, and Germany were the three principal markets for Croatia's imports of retail sale medicaments containing insulin, hormones, or antibiotics in value terms, collectively accounting for 72.6% of total imports.

Structure of product's imports in value by countries, 2017-2020

World map of product's imports to Croatia in value, 2017-2020